Since the first facial transplantation in 2005, 28 have been done worldwide with
encouraging immunological, functional, psychological, and aesthetic outcomes. Unlike solid …

The first Banff vascularized composite allotransplantation meeting was held in 2007 to
standardize criteria for the characterization and reporting of severity and types of rejection …

Background. Hagenia abyssinica (Bruce) JF Gmel (Rosaceae) is distributed in the highlands
of Ethiopia. The flowers of Hagenia abyssinica (Bruce) JF Gmel are used traditionally to treat …

Vascularized composite allotransplantation (VCA) is a novel therapeutic option for treatment
of patients suffering from limb loss or severe facial disfigurement. To date, 72 hand and 19 …

Vascularized composite allograft (VCA) transplantation, or reconstructive transplantation,
has revolutionized the treatment of complex tissue and functional defects. Despite arriving …

Recent evidences indicate an important role of tissue inflammatory responses by innate
immune cells in allograft acceptance and survival. Here we investigated the role of mast …

Genetic engineering is a promising tool to repair genetic disorders, improve graft function, or
reduce immune responses toward allografts. Ex vivo organ perfusion systems have the …

After the first face transplantation from woman to woman we performed in our clinic, it was
aimed to eliminate the lack of knowledge about the subject in the literature by transferring …

Vascularized composite allotransplantation (VCA) is a relatively new field in reconstructive
medicine. Likely a result of the unique tissue composition of these allografts—including skin …

Acute skin rejection in vascularized composite allotransplantation (VCA) is the major
obstacle for wider adoption in clinical practice. This study utilized computational modeling to …